Given the central role of GAPDH in energy metabolism and redox signaling, developing a more complete understanding of the biochemical mechanisms giving rise to modified GAPDH with S-glutathione and bound G(SS)G and the consequences thereof may assist in the discovery of novel therapeutic interventions for both acute and chronic vascular and neurodegenerative diseases. This evidence concerns the gene GAPDH and neurodegenerative disease.